93 related articles for article (PubMed ID: 23701484)
1. Pretreatment MRI of lymph nodes in rectal cancer: an opinion-based review.
Beets-Tan RG
Colorectal Dis; 2013 Jul; 15(7):781-4. PubMed ID: 23701484
[No Abstract] [Full Text] [Related]
2. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
[TBL] [Abstract][Full Text] [Related]
3. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria.
Lambregts DM; Heijnen LA; Maas M; Rutten IJ; Martens MH; Backes WH; Riedl RG; Bakers FC; Cappendijk VC; Beets GL; Beets-Tan RG
Abdom Imaging; 2013 Aug; 38(4):720-7. PubMed ID: 22986353
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer.
Jao SY; Yang BY; Weng HH; Yeh CH; Lee LW
Colorectal Dis; 2010 Nov; 12(11):1139-48. PubMed ID: 19548900
[TBL] [Abstract][Full Text] [Related]
5. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
Mohr U; Weissleder R
Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
7. Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model.
Herborn CU; Lauenstein TC; Vogt FM; Lauffer RB; Debatin JF; Ruehm SG
AJR Am J Roentgenol; 2002 Dec; 179(6):1567-72. PubMed ID: 12438057
[TBL] [Abstract][Full Text] [Related]
8. A new model of rectal cancer with regional lymph node metastasis allowing in vivo evaluation by imaging biomarkers.
Minicozzi AM; Conti G; Merigo G; Marzola P; Boschi F; Calderan L; Pacca R; Sbarbati A; Cordiano C
Biomed Pharmacother; 2011 Sep; 65(6):401-6. PubMed ID: 21719244
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of lymph node metastases: comparison of gadofluorine M-enhanced MRI and diffusion-weighted MRI in a rabbit VX2 rectal cancer model.
Kim SH; Lee JM; Moon SK; Chung YE; Paik JH; Choi SH; Kim MU; Han JK; Choi BI
J Magn Reson Imaging; 2012 May; 35(5):1179-86. PubMed ID: 22247081
[TBL] [Abstract][Full Text] [Related]
10. Early MR lymphography with gadofluorine M in rabbits.
Misselwitz B; Platzek J; Weinmann HJ
Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of metastatic from non-metastatic mesorectal lymph nodes in rectal cancer using quantitative dynamic contrast-enhanced magnetic resonance imaging.
Yu XP; Wen L; Hou J; Wang H; Lu Q
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):594-600. PubMed ID: 27465339
[TBL] [Abstract][Full Text] [Related]
12. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography.
Liu NF; Lu Q; Jiang ZH; Wang CG; Zhou JG
J Vasc Surg; 2009 Apr; 49(4):980-7. PubMed ID: 19223143
[TBL] [Abstract][Full Text] [Related]
13. [The magnetic resonance tomographic differential diagnosis between reactively enlarged lymph nodes and cervical lymph node metastases].
Steinkamp HJ; Heim T; Schubeus P; Schörner W; Felix R
Rofo; 1992 Oct; 157(4):406-13. PubMed ID: 1391845
[TBL] [Abstract][Full Text] [Related]
14. The role of EUS and MRI in rectal cancer staging.
Rovera F; Dionigi G; Boni L; Cutaia S; Diurni M; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S51-2. PubMed ID: 18032030
[TBL] [Abstract][Full Text] [Related]
15. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. what is the optimal criterion?
Matsuoka H; Nakamura A; Sugiyama M; Hachiya J; Atomi Y; Masaki T
Anticancer Res; 2004; 24(6):4097-101. PubMed ID: 15736458
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer].
Zhuang XZ; Yu SP; Cui J; Chen CQ; Zhao XJ; Pan BT; Li ZP
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):842-5. PubMed ID: 22116716
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of fat clearance and fat lucidification in examining rectal cancer specimen].
Liu JW; Lai DM; Li YR; Zhou J; Zhang YC; Yang B; Chen S
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):276-8. PubMed ID: 20422484
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted imaging of the male pelvis.
Koh DM; Sohaib A
Radiol Clin North Am; 2012 Nov; 50(6):1127-44. PubMed ID: 23122042
[TBL] [Abstract][Full Text] [Related]
19. The importance of not overstaging mesorectal lymph nodes seen on MRI.
Chand M; Heald RJ; Brown G
Colorectal Dis; 2013; 15(10):1201-4. PubMed ID: 24164749
[No Abstract] [Full Text] [Related]
20. Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model.
Lee JY; Choi BI; Son KR; Lee JM; Kim SJ; Park HS; Chang JM; Choi SH; Kim MA; Moon WK
Radiology; 2012 May; 263(2):391-400. PubMed ID: 22517957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
